Gail Nunlee-Bland to United States
This is a "connection" page, showing publications Gail Nunlee-Bland has written about United States.
Connection Strength
0.102
-
Mondal T, Loffredo CA, Simhadri J, Nunlee-Bland G, Korba B, Johnson J, Cotin S, Moses G, Quartey R, Howell CD, Noreen Z, Arif M, Ghosh S. Insights on the pathogenesis of type 2 diabetes as revealed by signature genomic classifiers in an African American population in the Washington, DC area. Diabetes Metab Res Rev. 2023 01; 39(1):e3589.
Score: 0.026
-
Warholak TL, Patel M, Rosenthal M, West-Strum D, Ettienne EB, Nunlee-Bland G, Nau D, Hincapie AL. Patient perceptions of a pharmacy star rating model. J Am Pharm Assoc (2003). 2017 May - Jun; 57(3):311-317.
Score: 0.018
-
Puckrein GA, Nunlee-Bland G, Zangeneh F, Davidson JA, Vigersky RA, Xu L, Parkin CG, Marrero DG. Impact of CMS Competitive Bidding Program on Medicare Beneficiary Safety and Access to Diabetes Testing Supplies: A Retrospective, Longitudinal Analysis. Diabetes Care. 2016 Apr; 39(4):563-71.
Score: 0.017
-
Laiyemo MA, Nunlee-Bland G, Lombardo FA, Adams RG, Laiyemo AO. Characteristics and health perceptions of complementary and alternative medicine users in the United States. Am J Med Sci. 2015 Feb; 349(2):140-4.
Score: 0.015
-
Caballero AE, Davidson J, Elmi A, Gavin J, Lee K, Nunlee-Bland GL, Zangeneh F, Puckrein GA. Previously unrecognized trends in diabetes consumption clusters in medicare. Am J Manag Care. 2013 Jul; 19(7):541-8.
Score: 0.014
-
Carter EL, Nunlee-Bland G, Callender C. A patient-centric, provider-assisted diabetes telehealth self-management intervention for urban minorities. Perspect Health Inf Manag. 2011 Jan 01; 8:1b.
Score: 0.012